The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.
Systematic biopsies always should be performed in conjunction with targeted biopsy in men with suspected clinically significant PCa at mpMRI.
The new test, IsoPSA, measures all PSA isoforms in serum and more accurately discriminates high-grade cancer from benign disease.
Patients with a pure variant had significantly lower survival odds than those with pure urothelial carcinoma over a median 6.5 years of follow up.
Just 1 in 4 patients diagnosed with metastatic urothelial carcinoma of the bladder survive for a year, according to US national registry data.
By 2014 to 2015, 1 in 3 bladder cancer surgical procedures performed in the United States were robot-assisted.
Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.
Five-year cancer-specific survival rates were 48.1% and 69.6% for PD-L1 positive and negative patients, respectively.
The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance.
A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.
Targeting PI-RADS 4 and 5 lesions for confirmatory biopsy improves detection of clinically significant cancer.
Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.
Lowest quartile of serum testosterone is associated with 48% and 65% increased odds of stress and mixed urinary incontinence, respectively.
Fusion biopsy has improved over the last decade and increasingly detects clinically significant prostate cancer, according to data trends from one institution.
Average International Prostate Symptom Score remained low 5 years after the PVP laser procedure.
Researchers identified a predictor of new-onset UI after HoLEP that may aid urologists in clinical practice.
In a study, 81.1% of men were able to void after an average of 28 days after treatment.
Highest quartile of alkaline phosphatase velocity in men who experience biochemical recurrence after radical prostatectomy is associated with 2-fold higher risk.
Systematic biopsy parameters identified patients at higher risk of positive surgical margins.
Among stage 2 to 4 bladder cancer patients, women had lower cancer-specific survival than men.
With Siamak Daneshmand, MD
With Stephen B. Williams, MD
With Kevin McVary, MD
With Kyle D. Wood, MD
With Zachary Klaassen, MD
With Joseph C. Liao, MD
With Luis Felipe Savio, MD
With A. Oliver Sartor, MD
With Vishnu Ganesan, MD
With Gary Steinberg, MD
With Jan Philipp Radtke, MD
With Stanley A. Yap, MD, MS
With Gregory E. Tasian MD, MSc, MSCE
With Stephen Freedland, MD
Renal and Urology News Articles
- AUA Issues New Guidelines on Testosterone Deficiency
- Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk
- Fenofibrate Therapy Slows CKD Progression in Diabetics
- Optimal Management of Oligometastatic Prostate Cancer Remains Unclear
- Post-Parathyroidectomy Predictors of Hungry Bone Syndrome Identified
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)